Delivery Order SPE2DB20D3103-SPE2DB25FQ4B7
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,580.18 to AmerisourceBergen Drug Corp for the supply of Uloric 80 mg tablets (30-count units) under a firm fixed-price contract type. The award was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and is classified as a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Uloric 80mg tablets. The award has a ceiling value of $2,990.19 and an ultimate completion date of November 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 19, 2025, for the supply of Uloric 80 mg tablets in quantities of 30 units under a firm fixed-price contract with a ceiling value of $2,424.82. This non-set-aside delivery order is scheduled for completion by May 20, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Uloric is a branded pharmaceutical used primarily in the treatment of chronic gout,...
- This federal contract award, identified as SPE2DB20D2104|SPE2DB24FU92F, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,167.06 firm fixed-price delivery order is for the pharmaceutical product Uloric 40 mg tablet 30s. The contract has an ultimate completion date of June 28, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov)....
- This federal contract award is for the delivery of ULORIC 40 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,423.79 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 10, 2022, with a completion date of June 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management...
- The Defense Logistics Agency awarded a delivery order valued at $2,323.73 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count) on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the DLA. The product will be delivered to the company's corporate office...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,633.92, is a delivery order contract with a firm fixed price for the supply of febuxostat 40 mg tablets. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,558,119,086 units of Febuxostat 40 mg tablets. The $2,347.52 firm fixed-price contract has an ultimate completion date of August 17, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,273.53 on July 28, 2025, for the supply of Febuxostat 80 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,353.14 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under...